Galectin Therapeutic (GALT)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Operating Expenses | 42,433 | 38,072 | 38,352 | 30,179 | 23,444 |
| Operating Income | -42,433 | -38,072 | -38,352 | -30,179 | -23,444 |
| Interest Expense | 5,540 | 2,792 | 1,033 | 489 | 87 |
| Other Income | 926 | -202 | 609 | 141 | 66 |
| Pre-tax Income | -47,047 | -41,066 | -38,776 | -30,527 | -23,465 |
| Net Income Continuous | -47,047 | -41,066 | -38,776 | -30,527 | -23,465 |
| Net Income | $-47,047 | $-41,066 | $-38,776 | $-30,527 | $-23,465 |
| EPS Basic Total Ops | -0.76 | -0.74 | -0.65 | -0.52 | -0.41 |
| EPS Basic Continuous Ops | -0.76 | -0.68 | -0.65 | -0.52 | -0.41 |
| EPS Diluted Total Ops | -0.76 | -0.74 | -0.65 | -0.52 | -0.41 |
| EPS Diluted Continuous Ops | -0.76 | -0.68 | -0.65 | -0.52 | -0.41 |
| EPS Diluted Before Non-Recurring Items | -0.76 | -0.74 | -0.65 | -0.52 | -0.41 |
| EBITDA(a) | $-42,396 | $-38,039 | $-38,320 | $-30,138 | $-23,408 |